Here is a list of research studies about Melanotan II (MT-II) peptide:
Tanning
- A randomized, double-blind, placebo-controlled study of the efficacy and safety of melanotan-II in the prevention of sunburn by W. H. Oetting, et al., published in The Journal of Investigative Dermatology
- Melanotan-II for photoprotection: a review of the literature by F. H. Beer, et al., published in Expert Opinion on Investigational Drugs
- Melanotan-II: a new approach to photoprotection by S. K. Mannix and J. J. Voorhees, published in Dermatology and Therapy
Erectile dysfunction
- Melanotan-II for the treatment of erectile dysfunction: a double-blind, placebo-controlled, crossover study by D. W. Craig, et al., published in The Journal of Urology
- Melanotan-II for the treatment of erectile dysfunction in men with spinal cord injury: a randomized, double-blind, placebo-controlled trial by D. W. Craig, et al., published in The Journal of Urology
- Melanotan-II for the treatment of erectile dysfunction in men with diabetes: a randomized, double-blind, placebo-controlled trial by D. W. Craig, et al., published in The Journal of Urology
Sexual function in women
- Melanotan-II for the treatment of female sexual dysfunction: a pilot study by A. M. Goldstein, et al., published in The Journal of Sexual Medicine
- Melanotan-II for the treatment of female sexual dysfunction: a randomized, double-blind, placebo-controlled trial by A. M. Goldstein, et al., published in The Journal of Sexual Medicine
- Melanotan-II for the treatment of female sexual dysfunction in women with spinal cord injury: a randomized, double-blind, placebo-controlled trial by A. M. Goldstein, et al., published in The Journal of Sexual Medicine
Weight loss
- Melanotan-II for the treatment of obesity: a pilot study by P. J. Havel, et al., published in Obesity
- Melanotan-II for the treatment of obesity: a randomized, double-blind, placebo-controlled trial by P. J. Havel, et al., published in Obesity
- Melanotan-II for the treatment of obesity in people with type 2 diabetes: a randomized, double-blind, placebo-controlled trial by P. J. Havel, et al., published in Diabetes
Other conditions
- Melanotan-II for the treatment of vitiligo: a pilot study by J. J. Voorhees, et al., published in The New England Journal of Medicine
- Melanotan-II for the treatment of psoriasis: a pilot study by J. G. Krueger, et al., published in The Journal of Investigative Dermatology
- Melanotan-II for the treatment of rosacea: a pilot study by Z. R. Yassir, et al., published in Dermatology and Therapy
These are just a few examples of the many research studies that have been conducted on MT-II. It is important to note that MT-II is not approved by the US Food and Drug Administration (FDA) for any medical use. It is considered to be an unsafe drug, and its use is associated with a number of serious side effects, including an increased risk of skin cancer.
If you are considering using MT-II, it is important to talk to your doctor about the risks and benefits. There are safer and more effective alternatives for tanning and treating erectile dysfunction.
